Ahead of Epam (EPAM) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Epam (EPAM) is anticipated to report Q2 earnings of $2.61 per share, marking a 6.5% year-over-year increase, with revenues projected at $1.33 billion, up 16.3%. However, the consensus EPS estimate has seen a 1.3% downward revision over the past 30 days, a factor analysts emphasize can significantly influence investor reaction. Despite strong projected growth in segments like Financial Services revenue (+27.9%), EPAM shares have underperformed, declining 17.4% in the last month against the S&P 500's positive movement, and currently hold a Zacks Rank #3 (Hold).

Analysis

Ahead of its Q2 earnings report, Epam (EPAM) is projected to deliver strong year-over-year growth, with consensus estimates pointing to a 16.3% revenue increase to $1.33 billion and a 6.5% rise in EPS to $2.61. This growth is expected to be driven by significant expansion in key industry verticals, most notably Financial Services, which is forecast to grow 27.9% YoY, and Emerging Verticals, with a projected 22.8% increase. However, these positive long-term indicators are contrasted by more cautious near-term signals. Critically, the consensus EPS estimate has been revised downward by 1.3% over the past 30 days, a factor often correlated with short-term stock price movements. This sentiment is mirrored in the market, where EPAM shares have declined 17.4% in the last month, substantially underperforming the S&P 500. The stock's Zacks Rank #3 (Hold) suggests it is expected to perform in line with the market, reflecting a balance between its solid underlying growth forecasts and the prevailing near-term headwinds.

Key Decisions for Investors

• Investors should weigh the robust projected YoY revenue growth against the negative signal of a 1.3% downward revision in consensus EPS estimates over the past month.
• Pay close attention to the revenue figures from the Financial Services vertical, as its high expected growth of 27.9% makes it a critical component for meeting or beating overall expectations.
• Given the significant stock underperformance of -17.4% recently despite strong growth forecasts, a neutral stance may be warranted, as the market appears to be pricing in near-term risks or a potential guidance disappointment.